EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Spectrum of rare EGFR mutations in Indonesian lung adenocarcinoma: Findings from an 8-year analysis of 4,778 cases highlighting the need for advanced targeted therapies

Didik S Heriyanto, Ika Trisnawati, Lisnawati Rachmadi, Jeffry B Tenggara, Vincent Lau, Andrew N Gunawan, Brigitta N Halim, Fara S Yuliani, Vincent Laiman, Soehartati Gondhowiardjo, Hsiao-Chi Chuang

Narra J · 2025

DOI: 10.52225/narra.v5i2.1721 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Narra J, 2025. Verfasst von Didik S Heriyanto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer patients in Indonesia exhibit a high prevalence of epidermal growth factor receptor (EGFR) mutations, with a substantial proportion attributed to rare or uncommon variants. The clinical significance of rare EGFR mutations lies in their differential sensitivity to tyrosine kinase inhibitors (TKIs). While they are frequently resistant to first- and second- generation TKIs, they often respond to third-generation TKIs, necessitating tailored treatment options. The need for improving access to advanced targeted therapies in Indonesia also highlights the importance of conducting research on rare EGFR mutations. The aim of this study was to identify the spectrum and frequency of EGFR mutations in patients with lung adenocarcinoma in Indonesia. A cross-sectional observational study with total sampling was conducted from January 2016 to April 2024 to investigate EGFR mutation profiles in lung adenocarcinoma patients. Samples were acquired from patients with a confirmed anatomical pathology diagnosis from various healthcare centers across Indonesia. A total of 4,778 samples were analyzed using real-time quantitative polymerase chain reaction (RT-qPCR) on various specimen types to determine EGFR mutation prevalence and patterns. Associations between demographic data and EGFR mutation status were assessed. EGFR mutations were detected in 54.6% of samples, with common mutations (exon 19 deletions/insertions and point mutation L858R) comprising 76.2% of positive cases and rare mutations (exon 20 insertions, point mutation G719X, S768I, T790M, and L861Q) accounted for 20.3%. Significant associations were found between geographic origin, age, and sex with EGFR mutation status. This study confirms substantial genetic variability and geographical differences in EGFR mutations among Indonesian lung adenocarcinoma patients, emphasizing the urgent need for further research to prompt enhanced molecular diagnostics and targeted therapies in the region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsMutationHumansIndonesiaMaleFemaleErbB ReceptorsMiddle AgedCross-Sectional StudiesAgedAdultProtein Kinase InhibitorsAged, 80 and over

Stichwörter der Autor:innen

EGFRLung cancergenomicslung adenocarcinomarare mutation

Substanzen

ErbB ReceptorsEGFR protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  • Department of Anatomical Pathology, Dr. Sardjito Hospital, Yogyakarta, Indonesia.
  • Division of Cardiac, Thoracic, and Vascular Surgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  • Division of Cardiac, Thoracic, and Vascular Surgery, Department of Surgery, Dr. Sardjito Hospital, Yogyakarta, Indonesia.
  • Collaboration Research Center for Precision Oncology based Omics-PKR PrOmics, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  • Division of Pulmonology, Department of Internal Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Zitieren

APA

Heriyanto, D. S., Trisnawati, I., Rachmadi, L., Tenggara, J. B., Lau, V., Gunawan, A. N., Halim, B. N., Yuliani, F. S., Laiman, V., Gondhowiardjo, S., & Chuang, H. C. (2025). Spectrum of rare EGFR mutations in Indonesian lung adenocarcinoma: Findings from an 8-year analysis of 4,778 cases highlighting the need for advanced targeted therapies. Narra J. https://doi.org/10.52225/narra.v5i2.1721

Vancouver

Heriyanto DS, Trisnawati I, Rachmadi L, Tenggara JB, Lau V, Gunawan AN, et al. Spectrum of rare EGFR mutations in Indonesian lung adenocarcinoma: Findings from an 8-year analysis of 4,778 cases highlighting the need for advanced targeted therapies. Narra J. 2025. doi:10.52225/narra.v5i2.1721

BibTeX
@article{Heriyanto2025,
  author = {Heriyanto, Didik S and Trisnawati, Ika and Rachmadi, Lisnawati and Tenggara, Jeffry B and Lau, Vincent and Gunawan, Andrew N and Halim, Brigitta N and Yuliani, Fara S and Laiman, Vincent and Gondhowiardjo, Soehartati and Chuang, Hsiao-Chi},
  title = {Spectrum of rare EGFR mutations in Indonesian lung adenocarcinoma: Findings from an 8-year analysis of 4,778 cases highlighting the need for advanced targeted therapies},
  journal = {Narra J},
  year = {2025},
  doi = {10.52225/narra.v5i2.1721}
}
Kostenlos starten →